Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Keane, WF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Novick, D; Schwartsburd, B; Pinkus, R; Suissa, D; Belzer, I; Sthoeger, Z; Keane, WF; Chvatchko, Y; Kim, SH; Fantuzzi, G; Dinarello, CA; Rubinstein, M
      A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensivedecrease of free IL-18

      CYTOKINE
    2. Keane, WF
      Metabolic pathogenesis of cardiorenal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    3. Brown, WW; Keane, WF
      Proteinuria and cardiovascular disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    4. Keane, WF; Mitch, WE; Fouque, D
      Advances in nutrition and metabolism in renal disease - 10th InternationalCongress on Nutrition and Metabolism in Renal Disease - Lyon, France - July 6-8, 2000 - Introduction

      AMERICAN JOURNAL OF KIDNEY DISEASES
    5. Keane, WF; Brenner, BM; Mazzu, A; Agro, A
      The CHORUS (Cerivastatin in heart outcomes in renal disease Understanding survival) protocol: A double-blind, placebo-controlled trial in patients with ESRD

      AMERICAN JOURNAL OF KIDNEY DISEASES
    6. Keane, WF
      Progression of renal disease - Introduction

      SEMINARS IN NEPHROLOGY
    7. Nemoto, T; Burne, MJ; Daniels, F; O'Donnell, MP; Crosson, J; Berens, K; Issekutz, A; Kasiske, BL; Keane, WF; Rabb, H
      Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure

      KIDNEY INTERNATIONAL
    8. Nemoto, T; Yokota, N; Keane, WF; Rabb, H
      Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure

      KIDNEY INTERNATIONAL
    9. Hebert, LA; Spetie, DN; Keane, WF
      The urgent call of albuminuria/proteinuria - Heeding its significance in early detection of kidney disease

      POSTGRADUATE MEDICINE
    10. Eknoyan, G; Levey, AS; Levin, NW; Keane, WF
      The national epidemic of chronic kidney disease - What we know and what wecan do

      POSTGRADUATE MEDICINE
    11. Brenner, BM; Cooper, ME; de Zeeuw, D; Keane, WF; Mitch, WE; Parving, HH; Remuzzi, G; Snapinn, SM; Zhang, ZX; Shahinfar, S
      Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

      NEW ENGLAND JOURNAL OF MEDICINE
    12. Khan, MA; Collins, AJ; Keane, WF
      Diabetes in the elderly population

      ADVANCES IN RENAL REPLACEMENT THERAPY
    13. Vas, SI; Keane, WF
      Treatment of peritonitis: Update or new course

      PERITONEAL DIALYSIS INTERNATIONAL
    14. Keane, WF; Bailie, GR; Boeschoten, E; Gokal, R; Golper, TA; Holmes, CJ; Kawaguchi, Y; Piraino, B; Riella, M; Vas, S
      Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update

      PERITONEAL DIALYSIS INTERNATIONAL
    15. Sica, DA; Halstenson, CE; Gehr, TWB; Keane, WF
      Pharmacokinetics and blood pressure response of losartan in end-stage renal disease

      CLINICAL PHARMACOKINETICS
    16. Keane, WF
      Proteinuria: Its clinical importance and role in progressive renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    17. Molitch, ME; DeFronzo, RA; Franz, MJ; Keane, WF; Mogensen, CE; Parving, HH; Steffes, MW
      Diabetic nephrology

      DIABETES CARE
    18. Keane, WF
      The role of lipids in renal disease: Future challenges

      KIDNEY INTERNATIONAL
    19. Massy, ZA; Kim, Y; Guijarro, C; Kasiske, BL; Keane, WF; O'Donnell, MP
      Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: Effects of oxidation and modulation by lovastatin

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    20. Keane, WF
      Lipids and progressive renal disease: The cardio-renal link

      AMERICAN JOURNAL OF KIDNEY DISEASES
    21. Keane, WF; Eknoyan, G
      Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the national kidney foundation

      AMERICAN JOURNAL OF KIDNEY DISEASES
    22. Keane, WF; Swan, SK; Grimes, I; Humphries, TJ
      Rabeprazole: Pharmacokinetics and tolerability in patients with stable, end-stage renal failure

      JOURNAL OF CLINICAL PHARMACOLOGY
    23. Keane, WF; Yukawa, S; Mune, M
      Lipids and renal disease - Introduction

      KIDNEY INTERNATIONAL
    24. Oda, H; Keane, WF
      Recent advances in statins and the kidney

      KIDNEY INTERNATIONAL
    25. Massy, ZA; Guijarro, C; O'Donnell, MP; Kim, YK; Kashtan, CE; Egido, J; Kasiske, BL; Keane, WF
      The central role of nuclear factor-kappa B in mesangial cell activation

      KIDNEY INTERNATIONAL
    26. Massy, ZA; Guijarro, C; Oda, H; Kasiske, BL; Keane, WF; O'Donnell, MP
      Importance of geranylgeranyl pyrophosphate for mesangial cell DNA synthesis

      KIDNEY INTERNATIONAL
    27. Guijarro, C; Blanco-Colio, LM; Massy, ZA; O'Donnell, MP; Kasiske, BL; Keane, WF; Egido, J
      Lipophilic statins induce apoptosis of human vascular smooth muscle cells

      KIDNEY INTERNATIONAL
    28. Oda, H; Kasiske, BL; O'Donnell, M; Keane, WF
      Effects of lovastatin on expression of cell cycle regulatory proteins in vascular smooth muscle cells

      KIDNEY INTERNATIONAL
    29. Keane, WF; Kasiske, BL
      Diagnostics and techniques

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    30. COLLINS AJ; KEANE WF
      HIGHER HEMATOCRIT LEVELS - DO THEY IMPROVE PATIENT OUTCOMES, AND ARE THEY COST-EFFECTIVE

      Nephrology, dialysis, transplantation
    31. ODA H; KEANE WF
      LIPID ABNORMALITIES IN END-STAGE RENAL-DISEASE

      Nephrology, dialysis, transplantation
    32. PARK YS; GUIJARRO C; KIM Y; MASSY ZA; KASISKE BL; KEANE WF; ODONNELL MP
      LOVASTATIN REDUCES GLOMERULAR MACROPHAGE INFLUX AND EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 MESSENGER-RNA IN NEPHROTIC RATS

      American journal of kidney diseases
    33. ODONNELL MP; CHAO CC; GEKKER G; MODI KS; KASISKE BL; KEANE WF
      RENAL-CELL CYTOKINE PRODUCTION STIMULATES HIV-1 EXPRESSION IN CHRONICALLY HIV-1-INFECTED MONOCYTES

      Kidney international
    34. KEANE WF; KASISKE BL
      THE RENAL CARDIOVASCULAR AXIS - NEW DIAGNOSTIC INSIGHTS

      Current opinion in nephrology and hypertension
    35. ODA H; SUGA S; KEANE WF; KASISKE BL; ODONNELL MP
      LOVASTATIN RETARDS THE EXPRESSION OF CYCLIN-D1 AND CYCLIN-E IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS STIMULATED BY PDGF-BB

      Journal of the American Society of Nephrology
    36. ODA H; SUGA S; KEANE WF; KASISKE BL; ODONNELL MP
      LOW-DENSITY-LIPOPROTEIN ACCELERATES THE CELL-CYCLE IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS STIMULATED BY PDGF

      Journal of the American Society of Nephrology
    37. ODA H; SUGA S; KEANE WF; KASISKE BL; ODONNELL MP
      SEQUENTIAL-CHANGES IN GLOMERULAR CYCLINS, CYCLIN-DEPENDENT KINASES AND CYCLIN-DEPENDENT KINASE INHIBITOR IN RATS WITH MESANGIAL PROLIFERATIVE INJURY

      Journal of the American Society of Nephrology
    38. SUGA S; ODA H; KEANE WF; KASISKE BL; ODONNELL MP
      LOW-DENSITY-LIPOPROTEIN (LDL) STIMULATES PROXIMAL TUBULAR EPITHELIAL-CELL (PTEC) SECRETION OF IL-6 AND TGF-BETA

      Journal of the American Society of Nephrology
    39. ODA H; SUGA S; KEANE WF; KASISKE BL; ODONNELL MP
      BRIEF EXPOSURE TO PDGF-BB IS SUFFICIENT TO INDUCE DNA-SYNTHESIS IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS

      Journal of the American Society of Nephrology
    40. KEANE WF; POLIS A; WOLF D; FAISON E; SHAHINFAR S
      THE LONG-TERM TOLERABILITY OF ENALAPRIL IN HYPERTENSIVE PATIENTS WITHRENAL IMPAIRMENT

      Nephrology, dialysis, transplantation
    41. KEANE WF
      DERANGEMENT OF LIPID-METABOLISM AND ITS MANAGEMENT IN RENAL-TRANSPLANT PATIENTS

      Mineral and electrolyte metabolism
    42. AWNI WM; WONG S; CHU SY; PATTERSON K; HANSEN R; MACHINIST JM; DRAJESK J; KEANE WF; HALSTENSON CE
      PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN PATIENTS WITH RENAL IMPAIRMENT

      Journal of clinical pharmacology
    43. ODA H; KEANE WF
      LIPIDS IN PROGRESSION OF RENAL-DISEASE

      Kidney international
    44. KEANE WF; BRENNER BM; KUROKAWA K
      PROGRESSION OF RENAL-DISEASE - CLINICAL-PATTERNS, THERAPEUTIC OPTIONS, AND LESSONS FROM CLINICAL-TRIALS - COOLUM, AUSTRALIA, MAY 31 JUNE 3 1997 - INTRODUCTION

      Kidney international
    45. GRIMM RH; SVENDSEN KH; KASISKE B; KEANE WF; WAHI MM
      PROTEINURIA IS A RISK FACTOR FOR MORTALITY OVER 10 YEARS OF FOLLOW-UP

      Kidney international
    46. ODONNELL MP; CRARY GS; ODA H; KASISKE BL; POWELL JR; KEANE WF
      IRBESARTAN LOWERS BLOOD-PRESSURE AND AMELIORATES RENAL INJURY IN EXPERIMENTAL NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Kidney international
    47. AWNI WM; WONG S; CHU SY; PATTERSON K; HANSEN R; MACHINIST JM; DRAJESK J; KEANE WF; HALSTENSON CE
      PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN SUBJECTS WITH RENAL IMPAIRMENT

      Clinical pharmacology and therapeutics
    48. RAGURAM PC; CRARY GS; SWAN SK; KASISKE BL; KIM Y; GRANTHAM JJ; KEANE WF; ODONNELL MP
      LOCALIZATION OF RAS IN CYSTIC EPITHELIAL-CELLS IN HUMAN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD)

      Journal of the American Society of Nephrology
    49. ODONNELL MP; GEKKER G; CHAO C; PETERSON PK; KEANE WF
      MESANGIAL CELL IL-6 PRODUCTION PROMOTES HIV-1 REPLICATION IN CHRONICALLY INFECTED U1 CELLS

      Journal of the American Society of Nephrology
    50. MASSY ZA; GUIJARRO C; KASISKE B; ODA H; KEANE WF; KIM Y; ODONNELL MP
      EFFECTS OF NATIVE AND OXIDIZED (OX) LOW-DENSITY-LIPOPROTEIN (LDL) ON MESANGIAL CELL EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) AND INTERLEUKIN-6 (IL-6) - MODULATION BY LOVASTATIN

      Journal of the American Society of Nephrology
    51. ODONNELL MP; CRARY GS; KASISKE BL; POWELL JR; KEANE WF
      THE ANGIOTENSIN-II RECEPTOR ANTAGONIST IRBESARTAN REDUCES BLOOD-PRESSURE AND RENAL INJURY IN OBESE ZUCKER RATS

      Journal of the American Society of Nephrology
    52. GUIJARRO C; KIM Y; SCHOONOVER CM; MASSY ZA; ODONNELL MP; KASISKE BL; KEANE WF; KASHTAN CE
      LOVASTATIN INHIBITS LIPOPOLYSACCHARIDE-INDUCED NF-KAPPA-B ACTIVATION IN HUMAN MESANGIAL CELLS

      Nephrology, dialysis, transplantation
    53. VAS SI; KEANE WF
      A LARGE STEP IN THE TREATMENT OF PERITONITIS IN PERITONEAL-DIALYSIS PATIENTS

      Peritoneal dialysis international
    54. KEANE WF; ALEXANDER SR; BAILIE GR; BOESCHOTEN E; GOKAL R; GOLPER TA; HOLMES CJ; HUANG CC; KAWAGUCHI Y; PIRAINO B; RIELLA M; SCHAEFER F; VAS S
      PERITONEAL DIALYSIS-RELATED PERITONITIS TREATMENT RECOMMENDATIONS - 1996 UPDATE

      Peritoneal dialysis international
    55. GUIJARRO C; KEANE WF
      EFFECTS OF LIPIDS ON THE PATHOGENESIS OF PROGRESSIVE RENAL-FAILURE - ROLE OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS IN THE PREVENTION OF GLOMERULOSCLEROSIS

      Mineral and electrolyte metabolism
    56. HIRATADULAS CAI; RITHNAJARIAN SJ; MCINTYRE MC; ROSS C; DAHL DC; KEANE WF; KASISKE BL
      RISK-FACTORS FOR NEPHROPATHY AND CARDIOVASCULAR-DISEASE IN DIABETIC NORTHERN MINNESOTA AMERICAN-INDIANS

      Clinical nephrology
    57. MASSY ZA; KEANE WF
      PATHOGENESIS OF ATHEROSCLEROSIS

      Seminars in nephrology
    58. MASSY ZA; KEANE WF; KASISKE BL
      INHIBITION OF THE MEVALONATE PATHWAY - BENEFITS BEYOND CHOLESTEROL REDUCTION

      Lancet
    59. KEANE WF
      LIPIDS AND PROGRESSIVE RENAL-FAILURE

      Wiener Klinische Wochenschrift
    60. CRARY GS; SWAN SK; ODONNELL MP; KASISKE BL; KATZ SA; KEANE WF
      THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN REDUCES BLOOD-PRESSURE BUT NOT RENAL INJURY IN OBESE ZUCKER RATS

      Journal of the American Society of Nephrology
    61. HIRATADULAS CAI; DAHL DC; MODI K; MA JZ; COLLINS AJ; KEANE WF
      SURVIVAL OF TYPE-II DIABETIC (DM-II) NATIVE-AMERICAN INDIANS (NAI) ONHEMODIALYSIS (HD) IS BETTER THAN CAUCASIANS

      Journal of the American Society of Nephrology
    62. MASSY ZA; KASISKE BL; GUIJARRO C; KIM Y; KEANE WF; ODONNELL MP
      BEYOND FARNESYL - ROLE OF GERANYLGERANYL(GG) IN HUMAN MESANGIAL CELL (HMC) DNA-SYNTHESIS STIMULATED BY PDGF

      Journal of the American Society of Nephrology
    63. GUIJARRO C; KASISKE BL; KIM YK; ODONNELL MP; LEE HS; KEANE WF
      EARLY GLOMERULAR CHANGES IN RATS WITH DIETARY-INDUCED HYPERCHOLESTEROLEMIA

      American journal of kidney diseases
    64. FOOTE EF; LOOK ZM; GILES P; KEANE WF; HALSTENSON CE
      THE PHARMACOKINETICS OF AMINOGUANIDINE IN END-STAGE RENAL-DISEASE PATIENTS ON HEMODIALYSIS

      American journal of kidney diseases
    65. BENNETT PH; HAFFNER S; KASISKE BL; KEANE WF; MOGENSEN CE; PARVING HH; STEFFES MW; STRIKER GE
      SCREENING AND MANAGEMENT OF MICROALBUMINURIA IN PATIENTS WITH DIABETES-MELLITUS - RECOMMENDATIONS TO THE SCIENTIFIC-ADVISORY-BOARD OF THE NATIONAL-KIDNEY-FOUNDATION FROM AN AD-HOC-COMMITTEE OF THE COUNCIL-ON DIABETES-MELLITUS OF THE NATIONAL-KIDNEY-FOUNDATION

      American journal of kidney diseases
    66. SICA DA; LO MW; SHAW WC; KEANE WF; GEHR TWB; HALSTENSON CE; LIPSCHUTZ K; FURTEK CI; RITTER MA; SHAHINFAR S
      THE PHARMACOKINETICS OF LOSARTAN IN RENAL-INSUFFICIENCY

      Journal of hypertension
    67. MOGENSEN CE; KEANE WF; BENNETT PH; JERUMS G; PARVING HH; PASSA P; STEFFES MW; STRIKER GE; VIBERTI GC
      PREVENTION OF DIABETIC RENAL-DISEASE WITH SPECIAL REFERENCE TO MICROALBUMINURIA

      Lancet
    68. WONG MO; ELDON MA; KEANE WF; TURCK D; BOCKBRADER HN; UNDERWOOD BA; SEDMAN AJ; HALSTENSON CE
      DISPOSITION OF GABAPENTIN IN ANURIC SUBJECTS ON HEMODIALYSIS

      Journal of clinical pharmacology
    69. FOOTE EF; LEE DR; KARIM A; KEANE WF; HALSTENSON CE
      DISPOSITION OF MISOPROSTOL AND ITS ACTIVE METABOLITE IN PATIENTS WITHNORMAL AND IMPAIRED RENAL-FUNCTION

      Journal of clinical pharmacology
    70. KIM SY; GUIJARRO C; ODONNELL MP; KASISKE BL; KIM YK; KEANE WF
      HUMAN MESANGIAL CELL PRODUCTION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1- MODULATION BY LOVASTATIN

      Kidney international
    71. KASISKE B; KEANE WF; VANRENTERGHEM Y
      CHRONIC RENAL-ALLOGRAFT FAILURE - CUENCA, SPAIN, JULY 7-9 1995 - INTRODUCTION

      Kidney international
    72. ODONNELL MP; KASISKE BL; MASSY ZA; GUIJARRO C; SWAN SK; KEANE WF
      ISOPRENOIDS AND RAS - POTENTIAL ROLE IN CHRONIC REJECTION

      Kidney international
    73. SWAN SK; CRARY GS; GUIJARRO C; ODONNELL MP; KEANE WF; KASISKE BL
      IMMUNOSUPPRESSIVE EFFECTS OF LEFLUNOMIDE IN EXPERIMENTAL CHRONIC VASCULAR REJECTION

      Transplantation
    74. GUIJARRO C; KEANE WF
      HYPERLIPIDEMIA AND NEPHROPATHY - CAUSE OR CONSEQUENCE

      Medicina Clinica
    75. STPETER JV; SWAN SK; HALSTENSON CE; KASISKE BL; COLLINS AJ; ELLEFSON J; KEANE WF
      ACCURATE AND EFFICIENT DETERMINATION OF RESIDUAL RENAL-FUNCTION (RRF)WITH IOHEXOL (IO) CLEARANCE IN HEMODIALYSIS (HD) PATIENTS

      Journal of the American Society of Nephrology
    76. GUIJARRO C; KIM Y; SHOONOVER CM; ODONNELL MP; KASISKE BL; KEANE WF
      LOVASTATIN (LOV) INHIBITS LIPOPOLYSACCHARIDE (LPS) STIMULATED MESANGIAL CELL (MC) NF-KAPPA-B ACTIVATION

      Journal of the American Society of Nephrology
    77. PARK YS; ODONNELL MP; KIM Y; KASISKE BL; GUIJARRO C; KEANE WF
      DIFFERENTIAL-EFFECTS OF LOVASTATIN ON GLOMERULAR AND INTERSTITIAL MACROPHAGE (M-PHI) INFILTRATION IN NEPHROTIC RATS

      Journal of the American Society of Nephrology
    78. ODONNELL MP; CHAO C; HU S; KEANE WF
      THE HIV-1 ENVELOPE PROTEIN GP120 STIMULATES MESANGIAL CELL PRODUCTIONOF TNF-A

      Journal of the American Society of Nephrology
    79. CRARY GS; SWAN SK; ODONNELL MP; KASISKE BL; KATZ SA; KEANE WF
      ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST LOWERS BLOOD-PRESSURE (BP) BUT DOES NOT REDUCE RENAL INJURY IN OBESE ZUCKER RATS

      Journal of the American Society of Nephrology
    80. GUIJARRO C; ODONNELL MP; KASISKE BL; KIM Y; MASSY ZA; KEANE WF
      OPPOSITE EFFECTS OF LOVASTATIN ON HUMAN MESANGIAL CELL MESSENGER-RNA EXPRESSION FOR IL-6 AND PDGF-B

      Journal of the American Society of Nephrology
    81. GUIJARRO C; ODONNELL MP; ATLURU D; KASISKE BL; KIM Y; KEANE WF
      LOVASTATIN (LOV) INHIBITS HUMAN MESANGIAL CELL (MC) PRODUCTION OF INTERLEUKIN-6 (IL-6)

      The FASEB journal
    82. ATLURU D; ODONNELL MP; GUIJARRO C; KEANE WF; KASISKE BL
      IMMUNOSUPPRESSIVE EFFECTS OF LEFLUNOMIDE IN CULTURED HUMAN MONONUCLEAR-CELLS

      The FASEB journal
    83. ATLURU D; ODONNELL MP; GUIJARRO C; KASISKE BL; GUDAPATY S; KEANE WF
      HUMAN MONONUCLEAR CELL-PROLIFERATION, BUT NOT INTERLEUKIN-6 PRODUCTION, IS DEPENDENT ON ISOPRENOID PRODUCTS OF MEVALONATE METABOLISM

      Biochemical archives
    84. KOPPLE JD; HAKIM RM; HELD PJ; KEANE WF; KING K; LAZARUS JM; PARKER TF; TEEHAN BP
      RECOMMENDATIONS FOR REDUCING THE HIGH MORBIDITY AND MORTALITY OF UNITED-STATES MAINTENANCE DIALYSIS PATIENTS

      American journal of kidney diseases
    85. KEANE WF; COLLINS AJ
      INFLUENCE OF CO-MORBIDITY ON MORTALITY AND MORBIDITY IN PATIENTS TREATED WITH HEMODIALYSIS

      American journal of kidney diseases
    86. HALSTENSON CE; WONG MO; JOHNSON CA; ZIMMERMAN SW; ONORATO JJ; KEANE WF; DOEPNER M; SIA L; TANTILLO K; BANSAL S; KUYE O; YACOBI A; FAULKNER R; LATHIA CD
      PHARMACOKINETICS OF TAZOBACTAM M1 METABOLITE AFTER ADMINISTRATION OF PIPERACILLIN TAZOBACTAM IN SUBJECTS WITH RENAL IMPAIRMENT/

      Journal of clinical pharmacology
    87. KEANE WF; MADIAS NE; HARRINGTON JT; PEREIRA B; SINGH A; LAFAYETTE R; NEURINGER J; NATOV SN
      LIPIDS AND THE KIDNEY

      Kidney international
    88. KEANE WF; BRENNER BM; PARVING HH
      PROGRESSION OF RENAL-DISEASE - INTRODUCTION - TIBERIAS, ISRAEL - JUNE20-22, 1993

      Kidney international
    89. KASISKE BL; ODONNELL MP; KIM YK; ATLURU D; KEANE WF
      CHOLESTEROL-SYNTHESIS INHIBITORS INHIBIT MORE THAN CHOLESTEROL-SYNTHESIS

      Kidney international
    90. GUIJARRO C; KEANE WF
      LIPID-INDUCED GLOMERULAR INJURY

      Nephron
    91. ODONNELL MP; GUIJARRO C; KIM Y; KASISKE BL; KEANE WF
      INDEPENDENT AND INTERACTIVE EFFECTS OF LDL AND IGF-1 ON MESANGIAL CELL-DNA SYNTHESIS AND EXPRESSION OF COLLAGEN MESSENGER-RNA

      Clinical research
    92. SWAN SK; STPETER JV; KASISKE BL; COLLINS AC; KEANE WF; HALSTENSON CE
      IOHEXOL CLEARANCE (CL(10)) AND RESIDUAL RENAL-FUNCTION (RRF) IN HEMODIALYSIS (HD) PATIENTS

      Clinical pharmacology and therapeutics
    93. SPRECHER DL; ABRAMS J; ALLEN JW; KEANE WF; CHRYSANT SG; GINSBERG H; FISCHER JJ; JOHNSON BF; THEROUX P; JOKUBAITIS L
      LOW-DOSE COMBINED THERAPY WITH FLUVASTATIN AND CHOLESTYRAMINE IN HYPERLIPIDEMIC PATIENTS

      Annals of internal medicine
    94. HARKER CT; ODONNELL MP; KASISKE BL; KEANE WF; KATZ SA
      THE RENIN-ANGIOTENSIN SYSTEM IN THE TYPE-II DIABETIC OBESE ZUCKER RAT

      Journal of the American Society of Nephrology
    95. KEANE WF; ODONNELL MP; KASISKE BL; KIM YK
      OXIDATIVE MODIFICATION OF LOW-DENSITY LIPOPROTEINS BY MESANGIAL CELLS

      Journal of the American Society of Nephrology
    96. FIORETTO P; KEANE WF; KASISKE BL; ODONNELL MP; KLEIN DJ; DANIELS FX; HOLDEN G
      ALTERATIONS IN GLOMERULAR PROTEOGLYCAN METABOLISM IN EXPERIMENTAL NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Journal of the American Society of Nephrology
    97. ATLURU D; HANSEN J; REMICK DG; ODONNELL MP; KASISKE BL; KEANE WF
      EFFECTS OF CYCLOSPORINE-A, FK-506 AND GENISTEIN ON IL-6, IL-8 PRODUCTION AND GENE-EXPRESSION BY HUMAN MONONUCLEAR-CELLS

      Biochemical archives
    98. KEANE WF; KASISKE BL
      LIPID HOMEOSTASIS AND THE KIDNEY - INTRODUCTION

      Mineral and electrolyte metabolism
    99. ODONNELL MP; KASISKE BL; KIM Y; ATLURU D; KEANE WF
      THE MEVALONATE PATHWAY - IMPORTANCE IN MESANGIAL CELL BIOLOGY AND GLOMERULAR-DISEASE

      Mineral and electrolyte metabolism
    100. ODONNELL MP; KASISKE BL; KIM YK; SCHMITZ PG; KEANE WF
      LOVASTATIN RETARDS THE PROGRESSION OF ESTABLISHED GLOMERULAR-DISEASE IN OBESE ZUCKER RATS

      American journal of kidney diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 02:09:40